Genelux (GNLX) Other Non-Current Assets (2022 - 2026)
Genelux's (GNLX) quarterly Other Non-Current Assets came in at $144000.0 in Q1 2026, little changed quarter-over-quarter from $144000.0 in Q4 2025.
Genelux (GNLX) Other Non-Current Assets (2022 - 2026) Analysis & Trends
Genelux's Other Non-Current Assets history runs 5 years deep, the most recent figure standing at $144000.0 for Q1 2026.
- On a quarterly basis, Other Non-Current Assets changed N/A year-over-year to $144000.0 in Q1 2026; TTM through Mar 2026 was $144000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $144000.0, up 56.52% from the prior year.
- Other Non-Current Assets was little changed at $144000.0 in Q1 2026 per GNLX's latest filing, from $144000.0 in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $144000.0 in Q4 2025 and bottomed at $73000.0 in Q2 2025.
- The 5-year median for Other Non-Current Assets is $92000.0 (2022), against an average of $102545.5.
- Biggest YoY gain for Other Non-Current Assets was 56.52% in 2025; the steepest drop was 20.65% in 2025.
- Year by year, Other Non-Current Assets stood at $92000.0 in 2022, then changed by 0.0% to $92000.0 in 2023, then changed by 0.0% to $92000.0 in 2024, then soared by 56.52% to $144000.0 in 2025, then changed by 0.0% to $144000.0 in 2026.
- Per Business Quant, the three latest GNLX Other Non-Current Assets figures stand at $144000.0 (Q1 2026), $144000.0 (Q4 2025), and $123000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 1.02 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 60,000.00 |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 104.24 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 1.26 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 2.13 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 124.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 14.48 Mn |
| 10 | Genelux | 129.36 Mn | 129.36 Mn | - | 144,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 144,000.00 |
| Dec 31, 2025 | 144,000.00 |
| Sep 30, 2025 | 123,000.00 |
| Jun 30, 2025 | 73,000.00 |
| Dec 31, 2024 | 92,000.00 |
| Sep 30, 2024 | 92,000.00 |
| Jun 30, 2024 | 92,000.00 |
| Mar 31, 2024 | 92,000.00 |
| Dec 31, 2023 | 92,000.00 |
| Sep 30, 2023 | 92,000.00 |
| Dec 31, 2022 | 92,000.00 |